Immunome, Inc. Shares Outstanding (Cover Page)
Immunome, Inc. (IMNM) had Shares Outstanding (Cover Page) of 113.58 million shares as of 2026-08-06, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-11
- 2026-08-06: Entity Common Stock, Shares Outstanding 113.58M shares.
- 2026-05-07: Entity Common Stock, Shares Outstanding 113.25M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 113.13M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 91.71M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-06 | 113.58M shares 10-Q · filed 2026-08-11 |
| 2026-05-07 | 113.25M shares 10-Q · filed 2026-05-12 |
| 2026-02-27 | 113.13M shares 10-K · filed 2026-03-03 |
| 2025-11-03 | 91.71M shares 10-Q · filed 2025-11-06 |
| 2025-08-04 | 87.05M shares 10-Q · filed 2025-08-06 |
| 2025-05-07 | 87.01M shares 10-Q · filed 2025-05-12 |
| 2025-03-14 | 86.95M shares 10-K · filed 2025-03-19 |
| 2024-11-08 | 62.42M shares 10-Q · filed 2024-11-13 |
| 2024-08-07 | 60.05M shares 10-Q · filed 2024-08-12 |
| 2024-05-06 | 59.97M shares 10-Q · filed 2024-05-14 |
| 2024-03-26 | 59.69M shares 10-K · filed 2024-03-28 |
| 2023-11-07 | 42.73M shares 10-Q · filed 2023-11-09 |
| 2023-08-07 | 12.20M shares 10-Q · filed 2023-08-09 |
| 2023-05-01 | 12.22M shares 10-Q · filed 2023-05-05 |
| 2023-03-13 | 12.22M shares 10-K · filed 2023-03-16 |
| 2022-11-10 | 12.13M shares 10-Q · filed 2022-11-14 |
| 2022-08-02 | 12.13M shares 10-Q · filed 2022-08-05 |
| 2022-05-09 | 12.13M shares 10-Q · filed 2022-05-12 |
| 2022-03-22 | 12.13M shares 10-K · filed 2022-03-28 |
| 2021-11-12 | 12.10M shares 10-Q · filed 2021-11-15 |
| 2021-08-12 | 11.81M shares 10-Q · filed 2021-08-16 |
| 2021-05-07 | 11.76M shares 10-Q · filed 2021-05-12 |
| 2021-03-22 | 10.66M shares 10-K · filed 2021-03-25 |
| 2020-10-31 | 10.54M shares 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |